Moderna COVID-19 Vaccine | FDA - U.S. Food and Drug Administration
Nov 4, 2024 · Information about Moderna COVID-19 Vaccine, Bivalent. Updated, bivalent mRNA COVID-19 vaccines are now FDA-authorized for all doses for individuals ages 6 months and …
Comparing the differences between COVID-19 vaccines
Sep 16, 2024 · Moderna COVID-19 vaccine 2024-2025 formula is authorized for people ages 6 months through 11 years. Spikevax is approved for people age 12 and older. The vaccines …
FDA Approves and Authorizes Updated mRNA COVID-19 Vaccines …
Today, the U.S. Food and Drug Administration approved and granted emergency use authorization (EUA) for updated mRNA COVID-19 vaccines (2024-2025 formula) to include a …
Moderna COVID-19 vaccine - Wikipedia
In January 2021, Moderna started development of a new form of its vaccine, called mRNA-1273.351, that could be used as a booster shot against the Beta variant (lineage B.1.351). [ …
Moderna COVID-19 Vaccine Summary | Vaccines & Immunizations …
Aug 28, 2024 · Moderna COVID-19 Vaccine 2024-2025 Formula is indicated for people 6 months through 11 years of age. Moderna SPIKEVAX ® is indicated for people 12 years and older
Pioneering mRNA technology - Moderna
Messenger RNA (mRNA) already exists in your body. It carries a “message” - instructions that direct your cells what to do. mRNA medicines fight diseases in a different way than traditional …
Moderna COVID-19 Vaccine At-A-Glance Guidance below summarizes basic storage, preparation, scheduling, administration, and dosage for all 2024–25 Moderna COVID-19 …
Moderna's COVID-19 Vaccine: What You Need to Know
Apr 30, 2024 · The Moderna vaccine is an mRNA vaccine, similar to the one developed by Pfizer. The technology behind these vaccines has been around for about three decades and shown …
The Moderna COVID-19 (mRNA-1273) vaccine: what you need …
Aug 18, 2022 · For adults aged 17 and above, SAGE recommends the use of the Moderna mRNA-1273 vaccine at a schedule of two doses (100 µg, 0.5 ml each) 8 weeks apart. For …
HHS Provides $590 Million to Accelerate Pandemic Influenza mRNA …
5 days ago · In addition, Moderna will design and test an H7N9 mRNA pandemic influenza vaccine in a phase 3 clinical study. If successful, this vaccine potentially could become the first …